Mitsui & Co. to Acquire Stake in Indian API Manufacturer

Mitsui & Co. (Tokyo) says it has entered into an agreement with Arch Pharmalabs (Mumbai), a pharmaceutical chemical intermediate and active pharmaceutical ingredients (API) manufacturer, to acquire about 5% of Arch for ¥1.2 billion ($14 million). The agreement makes Mitsui one of the first Japanese conglomerates to acquire a stake in an Indian pharmaceutical contract manufacturing organization (CMO), Mitsui says. Through this investment, Mitsui aims to strengthen the CMO business platform. India has a huge potential for manufacturing pharmaceutical...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers